Precigen (PGEN) Return on Sales (2016 - 2025)
Historic Return on Sales for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to 50.08%.
- Precigen's Return on Sales fell 249200.0% to 50.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 39.13%, marking a year-over-year decrease of 122500.0%. This contributed to the annual value of 4.02% for FY2022, which is 27100.0% up from last year.
- Precigen's Return on Sales amounted to 50.08% in Q3 2025, which was down 249200.0% from 31.12% recorded in Q2 2025.
- Precigen's Return on Sales' 5-year high stood at 5.68% during Q3 2022, with a 5-year trough of 82.0% in Q2 2024.
- In the last 5 years, Precigen's Return on Sales had a median value of 0.18% in 2021 and averaged 14.29%.
- Per our database at Business Quant, Precigen's Return on Sales plummeted by -863000bps in 2024 and then surged by 508700bps in 2025.
- Quarter analysis of 5 years shows Precigen's Return on Sales stood at 0.45% in 2021, then soared by 789bps to 4.02% in 2022, then grew by 7bps to 4.3% in 2023, then tumbled by -486bps to 16.58% in 2024, then crashed by -202bps to 50.08% in 2025.
- Its Return on Sales was 50.08% in Q3 2025, compared to 31.12% in Q2 2025 and 40.38% in Q1 2025.